ClinicalTrials.Veeva

Menu

Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients

P

Poitiers University Hospital

Status

Unknown

Conditions

Ventilator Associated Pneumonia

Treatments

Other: Bacterial species isolated

Study type

Observational

Funder types

Other

Identifiers

NCT04344509
PAVM COVID

Details and patient eligibility

About

National multicentric observational retrospective case-control study comparing the relative frequency of the various microorganisms responsible for VAP in patients infected or not by SARS-CoV-2 and their resistance to antibiotics.

Enrollment

10,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France.

Exclusion criteria

  • All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France.

Trial design

10,000 participants in 2 patient groups

COVID19-positive patients
Treatment:
Other: Bacterial species isolated
COVID19-negative patients
Treatment:
Other: Bacterial species isolated

Trial contacts and locations

0

Loading...

Central trial contact

Christophe BURUCOA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems